This inventor holds 4 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 4 EPO patents. Top assignees: Anaeropharma Science, Inc., Shinshu University. Active years: 2014-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Nagano, JP (2014 - 2020)
- Matsumoto, JP (2021)
Company Filing History:
4 out of 13 
1 out of 128 
Years Active: 2014-2021
Title: Yuko Shimatani: Innovator in Therapeutic Agents for Ischemic Diseases
Introduction
Yuko Shimatani is a prominent inventor based in Nagano, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for ischemic diseases. With a total of 4 patents to her name, her work focuses on innovative solutions for medical challenges.
Latest Patents
Yuko Shimatani's latest patents include groundbreaking inventions aimed at treating ischemic diseases. One of her notable patents involves a transformation plasmid designed for transforming anaerobes, which enables highly efficient and stable secretory expression of target proteins. This invention also includes a gene delivery carrier formed from the transformed anaerobes, a pharmaceutical composition incorporating this carrier, and methods for diagnosing or treating ischemic diseases using these innovations. Additionally, she has developed a co-expression plasmid that enhances therapeutic effects on anaerobic sites, such as solid tumor tissues and ischemic disease sites. This bacterium, transformed with a plasmid co-expressing two types of heterologous polypeptides, efficiently secretes antibodies with anticancer effects outside the bacterial cell.
Career Highlights
Throughout her career, Yuko Shimatani has worked with notable organizations, including Anaeropharma Science, Inc. and Shinshu University. Her research and inventions have significantly advanced the understanding and treatment of ischemic conditions, showcasing her dedication to improving healthcare outcomes.
Collaborations
Yuko has collaborated with esteemed colleagues, including Takeshi Masaki and Koichi Koseki. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Yuko Shimatani stands out as a leading inventor in the field of therapeutic agents for ischemic diseases. Her innovative patents and collaborative efforts reflect her commitment to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile